Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Venous Thromboembolism 8Venous Thrombosis 6Neoplasms 6Pulmonary Embolism 5Thromboembolism 3Lung Neoplasms 3Multiple Myeloma 2Lymphoma 2Colorectal Neoplasms 2Vascular Diseases 1Urogenital Neoplasms 1Thrombosis 1Thrombocytopenia 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Myeloproliferative Disorders 1Lymphoproliferative Disorders 1Lymphatic Diseases 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Intestinal Neoplasms 1Hemostatic Disorders 1Hemorrhage 1Digestive System Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

dacetuzumab 2Bortezomib 2epratuzumab 1edoxaban 1Vorinostat 1Ultrasonography 1Tranexamic Acid 1Tinzaparin 1Saline Solution 1Lenalidomide 1Enoxaparin 1Dipyrone 1Dexamethasone 1Calcium Dobesilate 1Blood Specimen Collection 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemostatic Disorders × Tinzaparin × Clear all
NCT03099031 2019-12-16

PREDICARE

LEO Pharma

Completed
420 enrolled
BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Digestive System Neoplasms, Intestinal Neoplasms, Leukemia, Lung Neoplasms, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Prostatic Neoplasms, Thromboembolism, Urogenital Neoplasms, Vascular Diseases, Colorectal Neoplasms, Hemostatic Disorders, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡